Austin Gastroenterology, Pa

Austin, Texas 78757

0 studies enrolling now · 15 studies all time

What they study most

Chronic Hepatitis, Colitis, Ulcerative, Constipation, Crohn's Disease, Hepatitis B, Hepatitis C, Hepatitis C, Chronic, Irritable Bowel Syndrome, Ulcerative Colitis

Studies at this site

• B0151005 Open-Label Extension Study — Completed
• Diarrhea Predominant Irritable Bowel Syndrome in Females — Completed
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis — Completed
• A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease — Completed
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis — Completed
• A Study of Abatacept in Patients With Active Ulcerative Colitis — Completed
• Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease — Completed
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis — Completed
• A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel Syndrome — Completed
• A Study of Abatacept in Patients With Active Crohn's Disease — Stopped early
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus — Stopped early
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus — Stopped early
• Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation — Completed
• Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin — Completed